Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04003363

The United Kingdom National Registry for Myotonic Dystrophy

Sponsor: Newcastle University

View on ClinicalTrials.gov

Summary

Myotonic dystrophy (dystrophia myotonica - DM) exists in two forms, usually referred to as DM1 (type 1) and DM2 (type 2). Both conditions are genetic disorders but each affects a different gene. DM1 is the most common adult-onset muscular dystrophy, and is thought to affect at least 1 in 8,000 people worldwide. The aim is to facilitate a questionnaire based research study in order to better characterise and understand the disease in the UK. By maintaining a national registry this will help identify potential participants eligible for clinical trials in the future.

Official title: The UK National Registry for Myotonic Dystrophy

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

900

Start Date

2013-05

Completion Date

2030-12

Last Updated

2023-12-04

Healthy Volunteers

No

Interventions

OTHER

Patient Registry

Participants who have volunteered to participate will complete various questionnaires relating to their condition.

Locations (1)

John Walton Muscular Dystrophy Research Centre

Newcastle upon Tyne, United Kingdom